William J. Febbo
CIK: 0001413987
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 25, 2026MYO
MYOMO, INC.
Award(A)Direct78.7K shares- - Apr 14, 2026MYO
MYOMO, INC.
Award(A)Direct45K shares- - Feb 14, 2025OPRX
OptimizeRx Corp
Tax Payment(F)Direct401 shares at avg. $6.64$3K - Dec 12, 2024OPRX
OptimizeRx Corp
Purchase(P)Direct20K shares at avg. $5.01$100K - Oct 2, 2024AUGX
Augmedix, Inc.
Disposition(D)Direct162.6K shares at avg. $2.35$382K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  MYO MYOMO, INC. | Award(A) | 78,704 | - | $0 | Direct |
| Apr 14, 2026 | MYO MYOMO, INC. | Award(A) | 45,000 | - | $0 | Direct |
| Feb 14, 2025 |  OPRX OptimizeRx Corp | Tax Payment(F) | 401 | $6.64 | $2,663 | Direct |
| Dec 12, 2024 | OPRX OptimizeRx Corp | Purchase(P) | 20,000 | $5.01 | $100,220 | Direct |
| Oct 2, 2024 |  AUGX Augmedix, Inc. | Disposition(D) | 162,583 | $2.35 | $382,070 | Direct |
1-5 of 5 transactions
About FEBBO WILLIAM J
FEBBO WILLIAM J (SEC CIK 0001413987) files insider reports with the SEC as Director of MYOMO, INC. (MYO), CEO of OptimizeRx Corp (OPRX) and Director of Augmedix, Inc. (AUGX).
Signal8 holds 6 ownership filings by FEBBO WILLIAM J (1 Form 3, 5 Form 4), filed between Oct 4, 2024 and Jun 26, 2026. Those filings report 5 transactions, from Oct 2, 2024 to Jun 25, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on FEBBO WILLIAM J's filings is in BURLINGTON, MA.
Recent filings by FEBBO WILLIAM J
- Jun 25, 2026: Grant or award of MYO shares (Form 4, code A).
- Apr 14, 2026: Grant or award of MYO shares (Form 4, code A).
- Feb 14, 2025: Tax withholding of OPRX shares (Form 4, code F).
- Dec 12, 2024: Open-market purchase of OPRX shares (Form 4, code P).
- Oct 2, 2024: Disposition to issuer transaction of AUGX shares (Form 4, code D).
Other insiders filing for MYOMO, INC. (MYO)
- Kovelman Harry, Chief Medical Officer
- HENRY DAVID A, Chief Financial Officer
- GUDONIS PAUL R, Chief Executive Officer
- McClure Mary-Katherine Hale, Chief Commericial Officer
- Morris Milton Mayo, Director
- Mitchell Micah, Chief Commercial Officer